Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.64M Buy
20,575
+59
+0.3% +$6.91K 0.52% 40
2026
Q1
$2.47M Buy
20,516
+297
+1% +$34.3K 0.56% 41
2025
Q4
$2.13M Buy
20,219
+3,882
+24% +$364K 0.56% 40
2025
Q3
$1.45M Sell
16,337
-9,915
-38% -$817K 0.42% 52
2025
Q2
$2.08M Sell
26,252
-135
-0.5% -$10.7K 0.68% 37
2025
Q1
$2.37M Buy
26,387
+28
+0.1% +$2.61K 0.88% 31
2024
Q4
$2.62M Buy
26,359
+43
+0.2% +$4.43K 1.06% 25
2024
Q3
$2.99M Buy
26,316
+469
+2% +$55.7K 1.22% 24
2024
Q2
$3.2M Buy
25,847
+381
+1% +$49.1K 1.46% 19
2024
Q1
$3.36M Buy
25,466
+889
+4% +$110K 1.54% 19
2023
Q4
$2.68M Sell
24,577
-419
-2% -$43.5K 1.52% 19
2023
Q3
$2.56M Buy
24,996
+85
+0.3% +$9.16K 1.7% 16
2023
Q2
$2.74M Buy
24,911
+100
+0.4% +$11.4K 1.77% 15
2023
Q1
$2.64M Hold
24,811
2.08% 15
2022
Q4
$2.74M Buy
24,811
+116
+0.5% +$11.9K 2.02% 14
2022
Q3
$2.18M Buy
24,695
+18,759
+316% +$1.67M 1.92% 14
2022
Q2
$541K Sell
5,936
-17,394
-75% -$1.54M 0.21% 82
2022
Q1
$1.91M Hold
23,330
1.55% 19
2021
Q4
$1.79M Buy
+23,330
New +$1.86M 1.5% 20

Other funds holding MRK

Next Level Private's MRK Position: Q2 2026 in Review

Next Level Private increased its Merck (MRK) stake by 0.29% in Q2 2026, buying an estimated $6.91K and bringing the position to 20,575 shares worth $2.64M. The position accounts for 0.52% of the portfolio, ranked #40.

Next Level Private first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.36M in Q1 2024. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Next Level Private held 20,575 shares of Merck worth $2.64M as of Q2 2026.
  • Next Level Private bought 59 Merck shares in Q2 2026, an estimated $6.91K.
  • Merck made up 0.52% of Next Level Private's portfolio in Q2 2026, its #40 holding.
  • Next Level Private first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Next Level Private's Merck position peaked at $3.36M in Q1 2024.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Next Level Private's 13F filing for Q2 2026, filed 9 Jul 2026.